REBECCA Real-world Early BrEast CanCer mAnagement

Trial Identifier: D0817R00068
Sponsor: AstraZeneca
Start Date: December 2024
Primary Completion Date: January 2028
Study Completion Date: January 2028
Condition: Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
France AGEN CEDEX 9, France
France ARGENTEUIL CEDEX, France
France AVIGNON CEDEX 9, France
France BEAUVAIS CEDEX, France
France BEUVRY, France
France BEZANNES, France
France CAEN, France
France CHAMBRAY LES TOURS, France
France CHAMPIGNY SUR MARNE CEDEX, France
France CLERMONT FERRAND CEDEX 2, France
France COMPIEGNE CEDEX, France
France CREIL CEDEX 1, France
France DECHY, France
France FORT DE FRANCE CEDEX, France
France FREJUS CEDEX, France
France GLEIZE, France
France GRENOBLE, France
France LE BLANC MESNIL, France
France LILLE CEDEX, France
France LIMOGES CEDEX 1, France
France LYON CEDEX 04, France
France MARSEILLE CEDEX 05, France
France METZ TESSY, France
France MONTPELLIER, France
France MONTPELLIER CEDEX 5, France
France NANCY, France
France NICE CEDEX 2, France
France OSNY, France
France PARIS CEDEX 14, France
France PERIGUEUX, France
France PLERIN CEDEX, France
France POITIERS CEDEX, France
France ROUEN CEDEX, France
France SALOUEL, France
France ST BRIEUC CEDEX 1, France
France ST DOULCHARD, France
France ST ETIENNE CEDEX 2, France
France ST GREGOIRE CEDEX, France
France ST MARTIN BOULOGNE, France
France ST PIERRE CEDEX, France
France ST PRIEST EN JAREZ CEDEX, France
France Thonon les bains, France
France VALENCE, France
France VALENCE CEDEX 9, France